More about Vijaya Diagnostic Centre Limited
Fundamentals for Vijaya Diagnostic Centre Limited
Regulatory Filings for Vijaya Diagnostic Centre Limited
IndiGo Implements Steep Fuel Surcharge as Iran Conflict Sends Jet Fuel Costs Soaring
The RBI's New Forex Fortress: Defensive Maneuvers in an Era of Oil Shocks
India's Fiscal Milestone: GST Collections Breach ₹2 Lakh Crore Mark for the First Time
AI Disruption Accelerates: Oracle Layoffs Raise Alarms for India’s Tech Workforce
Fundamentals for Vijaya Diagnostic Centre Limited
Business Operations:
Sector: HealthcareIndustry: Diagnostics & Research
Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Revenue projections:
With Vijaya Diagnostic Centre Limited's revenues expected to fall below the previous year's, investors are likely to approach the stock with caution. Declining revenues can negatively affect profitability, which makes it harder for the company to maintain investor confidence and perform well in the market.
Financial Ratios:
| currentRatio | 1.999000 |
|---|---|
| forwardPE | 48.001907 |
| debtToEquity | 42.224000 |
| earningsGrowth | 0.029000 |
| revenueGrowth | 0.102000 |
| grossMargins | 0.846840 |
| operatingMargins | 0.295490 |
| trailingEps | 14.730000 |
| forwardEps | 19.920000 |
VIJAYA's current ratio of 1.999 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring VIJAYA is unlikely to face difficulties in meeting immediate financial obligations.
VIJAYA's positive gross and operating margins suggest strong profitability. These margins reflect effective cost management and revenue generation, indicating that the company is efficiently managing its operations and maintaining financial health.
VIJAYA's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that VIJAYA is likely to outperform its previous year's financial performance.
Price projections:
VIJAYA's stock price has regularly been near the lower end of projections, indicating that it may be struggling to attract investor interest. This pattern suggests a cautious sentiment surrounding the company's future performance.
Recommendation changes over time:
Analysts have maintained a buy bias for Vijaya Diagnostic Centre Limited, which could prompt investors to consider the stock as a viable investment. With this positive outlook, Vijaya Diagnostic Centre Limited is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
U.S. Labor Market in 2026: JOLTS and Consumer Confidence Reveal Why Hiring Cooled Without Unemployment Spike
Lending Unleashed: Assessing the Impact of the Federal Reserve’s Capital Rollback
Calendar Collision: How Mahavir Jayanti's Overlap With Fiscal Year-End Reshapes India's Tax-Loss Harvesting Landscape